Adagene Interest Expense 2011-2026 | ADAG

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Adagene

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	1.11 M	693 K	364 K	202 K	138 K	91.1 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.11 M	91.1 K	433 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
ANI Pharmaceuticals ANIP	-4.03 M	$ 81.6	-0.49 %	$ 1.58 B	USA
Aeglea BioTherapeutics AGLE	-20.7 M	-	-	$ 1.01 B	USA
Aytu BioScience AYTU	-512 K	$ 2.63	1.74 %	$ 16.5 M	USA
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.17	-2.76 %	$ 7.63 B	Australia
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Biogen BIIB	250 M	$ 178.24	1.2 %	$ 26 B	USA
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	65.5 M	$ 225.36	0.63 %	$ 5 B	Danmark
Athira Pharma ATHA	3.96 M	-	-	$ 269 M	USA
Atreca BCEL	3 K	-	-11.76 %	$ 5.79 M	USA
Arrowhead Pharmaceuticals ARWR	5.26 M	$ 70.74	2.34 %	$ 9.46 B	USA
CASI Pharmaceuticals CASI	2.9 K	$ 0.99	-0.01 %	$ 135 M	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Catalyst Biosciences CBIO	1.04 M	$ 9.63	-5.08 %	$ 634 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	2.66 M	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	-807 K	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 4.05	-1.22 %	$ 8.81 B	Israel
Amneal Pharmaceuticals AMRX	11.8 M	$ 13.65	-3.3 %	$ 4.22 B	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Cerus Corporation CERS	1.98 M	$ 2.32	-0.22 %	$ 428 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA